12.19
0.15 (1.25%)
| Previous Close | 12.04 |
| Open | 12.35 |
| Volume | 1,211,981 |
| Avg. Volume (3M) | 2,242,767 |
| Market Cap | 2,658,102,784 |
| Price / Sales | 2.86 |
| Price / Book | 1.19 |
| 52 Weeks Range | |
| Earnings Date | 8 Oct 2026 |
| Profit Margin | -53.56% |
| Operating Margin (TTM) | 2.45% |
| Diluted EPS (TTM) | -2.23 |
| Quarterly Revenue Growth (YOY) | -3.40% |
| Total Debt/Equity (MRQ) | 33.61% |
| Current Ratio (MRQ) | 3.91 |
| Operating Cash Flow (TTM) | 68.45 M |
| Levered Free Cash Flow (TTM) | 1.26 M |
| Return on Assets (TTM) | 0.59% |
| Return on Equity (TTM) | -16.71% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Neogen Corporation | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 1.5 |
| Price Volatility | -5.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 4.0 |
| Average | 0.50 |
|
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 0.38% |
| % Held by Institutions | 128.88% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| NASSIF MIKHEAL | 11.81 | - | 370 | 4,370 |
| Aggregate Net Quantity | 370 | |||
| Aggregate Net Value ($) | 4,370 | |||
| Aggregate Avg. Buy ($) | 11.81 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| NASSIF MIKHEAL | Officer | 04 Aug 2026 | Buy (+) | 370 | 11.81 | 4,370 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |